Executive Director, US Brand Lead – Oncology Biosimilars

About the role

The Executive Director, US Brand Lead for ABP 206 & ABP 234 is accountable for leading the US commercial market readiness strategy for two of Amgen's highest priority oncology biosimilars assets. This leader serves as the single-point commercial owner responsible for building a team and designing and delivering an integrated commercial strategy that prepares the organization for successful market entry while positioning both brands for long-term growth and sustained market leadership.

Responsibilities

• Own the comprehensive US commercial market readiness strategy for ABP 206 and ABP 234, ensuring the organization is prepared for successful market entry.
• Define the commercial ambition, strategic priorities, success metrics, and critical milestones across both assets.
• Lead integrated market readiness planning across Marketing, Sales, Medical, Market Access, Patient Support, Digital, Regulatory, Corporate Affairs, Operations, and other key functions.
• Establish governance, decision-making processes, execution discipline, and accountability across a highly matrixed organization.
• Lead commercial scenario planning and proactively identify risks and mitigation strategies across regulatory, competitive, access, reimbursement, contracting, and supply considerations.
• Define the US commercial opportunity by identifying target patient populations, treatment settings, customer segments, and key decision-makers.
• Serve as Amgen's commercial authority on the evolving biosimilar marketplace, competitive dynamics, customer behaviors, treatment pathways, and market trends.
• Identify unmet customer needs, barriers to adoption, and market opportunities that inform differentiated commercial strategies and accelerate market readiness.
• Translate complex market insights into clear commercial priorities that position both assets for long-term success.
• Lead development of differentiated US brand strategies, positioning, value propositions, and long-term growth narratives for both assets.
• Partner closely with the Biosimilar Business Unit to shape worldwide strategy while ensuring execution reflects the unique needs of the US oncology marketplace.
• Develop compelling, evidence-based messaging that resonates across healthcare providers, health systems, payers, patients, and internal stakeholders.
• Lead market-shaping initiatives that prepare customers and stakeholders for the introduction of both assets while supporting appropriate adoption and access.
• Lead integrated commercial planning across both brands, including strategic planning, investment prioritization, forecasting assumptions, resource allocation, and performance objectives.
• Drive execution through disciplined milestone management, executive reporting, and cross-functional performance reviews.
• Monitor market dynamics and adjust commercial strategies to respond to changing customer needs, competitive actions, reimbursement environments, and regulatory developments.
• Partner with Finance and Commercial Operations to support forecasting, business planning, and resource optimization.
• Cross-Functional Leadership & Enterprise Collaboration:
• Lead a highly integrated cross-functional team spanning Marketing, Sales, Medical, Market Access, Value & Evidence, Digital, Corporate Affairs, Patient Support, Operations, and Global Commercial.
• Build strong partnerships across the enterprise to ensure alignment, rapid decision-making, and execution excellence.
• Influence enterprise priorities while representing the commercial perspective across governance forums and senior leadership discussions.
• Ensure strong integration between Global and US teams, providing meaningful US market input to global commercialization strategies.
• Field Readiness & Market Access:
• Ensure the Field organization is commercially prepared with effective strategies, training, tools, messaging, and customer engagement resources.
• Partner with Market Access to develop pricing, reimbursement, contracting, and access strategies that support successful commercialization.
• Oversee development of patient support programs and customer solutions that improve access and enable positive customer experiences.
• External Engagement & Market Influence:
• Represent Amgen as a senior commercial leader with key external stakeholders, including professional societies, customer advisory boards, strategic partners, and other influential organizations.
• Monitor the external healthcare environment to anticipate emerging trends, competitive threats, and evolving customer expectations.
• Help shape the commercial narrative for Amgen's oncology biosimilar portfolio through strategic external engagement.
• People, Culture & Leadership:
• Build, develop, and inspire a high-performing commercial organization focused on collaboration, accountability, inclusion, innovation, and execution excellence.
• Coach and develop future commercial leaders while fostering an environment of continuous learning and talent development.
• Partner with the OBU General Manager, OBU Senior Leadership Team, and peer Brand Leads to strengthen organizational effectiveness and deliver outstanding business results.

Requirements

• Doctorate degree & 6 years of oncology or commercialization experience OR
• Master’s degree & 10 years of oncology or commercialization experience OR
• Bachelor’s degree & 12 years of oncology or commercialization experience AND 6 years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs or directing the allocation of resources

Preferred Qualifications

• Commercial Leadership 8+ years of progressive commercial leadership experience within the biopharmaceutical or biotechnology industry.
• Commercial market readiness for major specialty or oncology products from pre-approval planning through successful market entry.
• Experience commercializing biosimilars or other highly competitive specialty products where market access, contracting, stakeholder education, and competitive differentiation are critical to success.
• Ability to lead complex commercial organizations through ambiguity, change, and rapidly evolving competitive environments.
• Strategic & Analytical Excellence: Experience translating customer insights, market dynamics, and scientific data into differentiated commercial strategies. Understanding of US market access, pricing, reimbursement, contracting, and healthcare policy. Analytical capabilities, including forecasting, scenario planning, business planning, and investment prioritization. Experience leading enterprise commercial planning and cross-functional decision-making.
• Leadership & Influence: Experience leading large, highly matrixed cross-functional organizations. Executive presence with exceptional communication, influencing, and organizational leadership skills. Ability to build alignment across senior leaders while driving accountability and execution.
• People leader with a passion for developing talent, building high-performing teams, and fostering an inclusive culture.
• Oncology experience strongly preferred. Experience in biosimilars, hematology/oncology, immuno-oncology, or other complex specialty markets is highly desirable. Experience leading commercialization strategies within highly competitive healthcare markets is preferred.